Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of RCVELP as First Line Therapy for Follicular Lymphoma (FL) and Marginal Zone Lymphoma (MZL)

NCT00772668 is registered in ClinicalTrials.gov with University of Miami as lead sponsor.

NCT NCT00772668
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00772668 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of RCVELP as First Line Therapy for Follicular Lymphoma (FL) and Marginal Zone Lymphoma (MZL)
Lead sponsor
University of Miami
Phase
Not applicable
Overall status
Terminated
Start date
September 25, 2009
Completion date
February 28, 2011
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

follicular lymphoma, lymphoma, marginal zone lymphoma